MEK inhibitor therapy was stopped immediately, although anterior uveitis developed 2 weeks later requiring treatment with topical corticosteroids and subsequently periocular triamcinolone acetonide injection.35 In our opinion, it is unlikely that the uveitis was associated with MEK inhibitor therapy. This evidence concerns the gene MAP2K7 and anterior uveitis.